Tus-Pharmaceutical Group Co., Ltd.
Symbol: 000590.SZ
SHZ
6.8
CNYTržní cena dnes
155.0687
Poměr P/E
2.6708
Poměr PEG
1.63B
MRK Cap
- 0.00%
Výnos DIV
Tus-Pharmaceutical Group Co., Ltd. (000590-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 767.96 | 189.8 | 260.5 | 325.8 | |||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 31.67 | 0 | 25.1 | 75.1 | |||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 756.24 | 215 | 147.8 | 141.5 | |||||||||||||||||||||||||||||
balance-sheet.row.inventory | 528.48 | 130.1 | 118.2 | 86.6 | |||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 18.97 | 4.7 | 2.6 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 2071.65 | 539.6 | 529.1 | 553.9 | |||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1172.35 | 293.8 | 289.7 | 240.9 | |||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 537.58 | 131.6 | 137.1 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 570.87 | 132.3 | 157.4 | 133.7 | |||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1108.45 | 264 | 294.6 | 133.7 | |||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 95.12 | 44.6 | -6.1 | -56.1 | |||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 17.36 | 4.1 | 5 | 5 | |||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 91.31 | 5.1 | 54.5 | 90.5 | |||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 2484.59 | 611.6 | 637.6 | 413.9 | |||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 4556.24 | 1151.1 | 1166.8 | 967.8 | |||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 228.31 | 47.6 | 64 | 41.7 | |||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 146.92 | 50.6 | 38.6 | 3 | |||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 17 | 2.3 | 16.8 | 8 | |||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 350.5 | 80 | 95.2 | 5.6 | |||||||||||||||||||||||||||||
Deferred Revenue Non Current | 170.73 | 42.4 | 44.4 | 46.3 | |||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 25.76 | - | - | - | |||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 211.71 | 100.4 | 112.7 | 9.6 | |||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 694.78 | 131.7 | 192.8 | 98.5 | |||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 18.3 | 3.1 | 5.2 | 5.6 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 1647.66 | 380.5 | 464.3 | 285.5 | |||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 957.89 | 239.5 | 239.5 | 239.5 | |||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -188.84 | -35.7 | -61 | -79.1 | |||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1325.12 | 142.6 | 142.6 | 142.6 | |||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 754.73 | 377.4 | 377.4 | 377.4 | |||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 2848.9 | 723.7 | 698.5 | 680.3 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4556.24 | 1151.1 | 1166.8 | 967.8 | |||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 17.24 | 4.5 | 4 | 2 | |||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 2866.14 | 728.2 | 702.5 | 682.3 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4556.24 | - | - | - | |||||||||||||||||||||||||||||
Total Investments | 126.79 | 44.6 | 19 | 19 | |||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 505.22 | 133.7 | 133.8 | 8.6 | |||||||||||||||||||||||||||||
balance-sheet.row.net-debt | -207.74 | -56.1 | -101.6 | -242.1 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 10.38 | 25.2 | 18.2 | 35.4 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.25 | 28.3 | 24.4 | 19.5 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -0.4 | 0.9 | -0.4 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -142.3 | -0.9 | 0.4 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -49.51 | -85.8 | 12 | -27.1 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -45.83 | -45.8 | 2.9 | -26.8 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -11.64 | -11.6 | -7.3 | -35.6 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -28.3 | 15.5 | 35.7 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 7.96 | 0 | 0.9 | -0.4 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 39.37 | 146.6 | -0.1 | -2.6 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0.49 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -19.62 | -22 | -18.7 | -25.9 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 1.41 | 1.2 | -214.5 | 2.7 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -309.9 | -391.9 | -826.5 | -1096.7 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 330.26 | 416.9 | 879.5 | 1005.8 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 55.38 | 0 | 2.7 | -2 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 2.16 | 4.2 | -177.5 | -116 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -69.64 | -25 | -18 | -5 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | -4.11 | -4.2 | -0.3 | -0.1 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -4.26 | -3.3 | 129.9 | -0.7 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -27.64 | -32.5 | 111.5 | -5.8 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 4.73 | 11.1 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | -21.85 | -45.7 | -11.5 | -96.6 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 704.39 | 189.8 | 234.8 | 246.4 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 726.24 | 235.4 | 246.4 | 343 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0.49 | -28.4 | 54.5 | 25.2 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -19.62 | -22 | -18.7 | -25.9 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | -19.13 | -50.4 | 35.8 | -0.7 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 376.25 | 395.9 | 350.5 | 300.8 | ||||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 186.52 | 206.1 | 171.3 | 134.5 | ||||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 189.73 | 189.9 | 179.2 | 166.3 | ||||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 12.12 | - | - | - | ||||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 16.01 | - | - | - | ||||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 86.86 | - | - | - | ||||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -6.43 | 0.1 | 73.1 | 68.6 | ||||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 203.26 | 183.8 | 163 | 132.2 | ||||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 389.78 | 389.8 | 334.3 | 266.7 | ||||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 2.51 | 2.2 | 3.4 | 4.3 | ||||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 4.36 | 4.5 | 1.2 | 0.5 | ||||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 86.86 | - | - | - | ||||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 28.98 | 23.6 | -0.8 | -0.5 | ||||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -6.43 | 0.1 | 73.1 | 68.6 | ||||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 28.98 | 23.6 | -0.8 | -0.5 | ||||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 4.36 | 4.5 | 1.2 | 0.5 | ||||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 11.55 | 28.3 | 24.5 | 20.6 | ||||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -3.1 | - | - | - | ||||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | -14.64 | 6.1 | 22.7 | 42.4 | ||||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 14.34 | 29.7 | 21.9 | 41.8 | ||||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 4.32 | 4.8 | 3.7 | 6.4 | ||||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 10.38 | 25.2 | 18.1 | 35.4 |
Často kladené otázky
Co je Tus-Pharmaceutical Group Co., Ltd. (000590.SZ) celková aktiva?
Tus-Pharmaceutical Group Co., Ltd. (000590.SZ) celková aktiva jsou 1151120901.000.
Jaký je roční obrat podniku?
Roční příjmy jsou 202818079.000.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.504.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.080.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.028.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou -0.039.
Co je Tus-Pharmaceutical Group Co., Ltd. (000590.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 25246778.000.
Jaký je celkový dluh podniku?
Celkový dluh je 133694137.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 183770179.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 166598619.000.